β2- and β3-adrenergic receptors drive COMT-dependent pain by increasing production of nitric oxide and cytokines.
β2- and β3-adrenergic receptors drive COMT-dependent pain by increasing production of nitric oxide and cytokines.
复制标题
DOI:
10.1016/j.pain.2014.04.011
复制
发表时间:
2014-07
期刊:
影响因子:
7.4
通讯作者:
Nackley AG
中科院分区:
文献类型:
--
作者:
Hartung JE;Ciszek BP;Nackley AG
Decreased activity of catechol-O-methyltransferase (COMT), an enzyme that metabolizes catecholamines, contributes to pain in humans and animals. Previously, we demonstrated that development of COMT-dependent pain is mediated by both β2- and β3-adrenergic receptors (β2-and β3ARs). Here, we investigated molecules downstream of β2-and β3ARs driving pain in animals with decreased COMT activity. Based on evidence linking their role in pain and synthesis downstream of β2- and β3AR stimulation, we hypothesized that nitric oxide (NO) and pro-inflammatory cytokines drive COMT-dependent pain. To test this, we measured plasma NO derivatives and cytokines in rats receiving the COMT inhibitor OR486 in the presence or absence of the β2AR antagonist ICI118,551 + β3AR antagonist SR59320A. We also assessed if the NO synthase inhibitor L-NG-nitroarginine methyl ester (L-NAME) and cytokine neutralizing antibodies block the development of COMT-dependent pain. Results showed that animals receiving OR486 exhibited higher levels of NO derivatives, tumor necrosis factor α (TNFα), interleukin-1β (IL-1β), interleukin-6 (IL-6), and chemokine (C-C motif) ligand 2 (CCL2) in a β2-and β3AR-dependent manner. Additionally, inhibition of NO synthases and neutralization of the innate immunity cytokines TNFα, IL-1β, and IL-6 blocked the development of COMT-dependent pain. Finally, we found that NO influences TNFα, IL-1β, IL-6 and CCL2 levels, while TNFα and IL-6 influence NO levels. Altogether, these results demonstrate that β2- and β3ARs contribute to COMT-dependent pain, at least partly, by increasing NO and cytokines. Furthermore, they identify β2- and β3ARs, NO, and pro-inflammatory cytokines as potential therapeutic targets for pain patients with abnormalities in COMT physiology.
登录
查看更多内容
影响因子:
3.5
作者:
Diatchenko, L;Slade, GD;Maixner, W
通讯作者:
Maixner, W
DOI:
10.1523/jneurosci.3795-08.2008
发表时间:
2008-12-24
期刊:
The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子:
--
作者:
Binshtok AM;Wang H;Zimmermann K;Amaya F;Vardeh D;Shi L;Brenner GJ;Ji RR;Bean BP;Woolf CJ;Samad TA
通讯作者:
Samad TA
DOI:
10.1073/pnas.0409225102
发表时间:
2005-02-01
影响因子:
11.1
作者:
Cunha, TM;Verri, WA;Ferreira, SH
通讯作者:
Ferreira, SH
影响因子:
4.8
作者:
Flach, Rachel J. Roth;Matevossian, Anouch;Czech, Michael P.
通讯作者:
Czech, Michael P.
影响因子:
3.3
作者:
Hodges, Gary J.;Kosiba, Wojciech A.;Johnson, John M.
通讯作者:
Johnson, John M.